The European Commission ‘Summary of the 2020 annual reporting of serious adverse reactions and events for blood and blood components’ is now available. Main findings include that only 21 out of 27 member states receive complete data from their establishments; 22.8 million units of blood or blood components were reported across countries; 1 674 serious adverse reactions, 2 604 serious adverse events and 26 deaths were reported. The full report is available here.